Medicare Enrolled
Dr. Kaushik Patel, MD
Critical Care Medicine · Champaign, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Kaushik Patel is a critical care medicine specialist in Champaign, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 3,521 Medicare services across 1,765 unique beneficiaries.
Between the years covered by Open Payments, Dr. Patel received a total of $18,945 from 51 pharmaceutical and/or device companies across 728 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in IL
$18,945 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,521
Medicare services
Top 2% in IL for critical care medicine
1,765
Unique beneficiaries
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~176 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Allergy blood test (IgE), per allergen A blood test that measures the level of immunoglobulin E (IgE) antibodies produced in response to a specific crude allergen extract. |
1,345 | $5 | $44 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
522 | $89 | $252 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
185 | $39 | $376 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
183 | $42 | $374 |
| Airflow rate measurement test A test that measures the rate of airflow. This procedure assesses how quickly air moves. |
103 | $27 | $264 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
98 | $27 | $376 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
97 | $8 | $32 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
81 | $57 | $171 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
73 | $8 | $67 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
71 | $11 | $57 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
66 | $122 | $397 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
60 | $0 | $2 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
60 | $1 | $3 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
44 | $281 | $710 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
44 | $30 | $32 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
44 | $30 | $32 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
43 | $72 | $175 |
| Nitric oxide gas level test A test that measures the level of nitric oxide gas in the body. |
40 | $12 | $139 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
37 | $63 | $271 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
36 | $26 | $100 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
35 | $95 | $409 |
| Lung cancer screening counseling visit A visit to discuss the need for lung cancer screening using a low-dose CT scan. This service is used to determine eligibility and facilitate shared decision making. |
33 | $27 | $199 |
| IgE level test A blood test that measures the level of immunoglobulin E (IgE) proteins in the immune system. |
32 | $16 | $145 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
28 | $11 | $111 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
26 | $157 | $1,380 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
24 | $10 | $111 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
24 | $62 | $228 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
21 | $104 | $525 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
19 | $86 | $263 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
13 | $128 | $696 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
12 | $15 | $54 |
| COVID-19 vaccine administration Administration of a single dose of the coronavirus vaccine. |
11 | $36 | $51 |
| COVID-19 vaccine (Pfizer bivalent) Administration of a 30 mcg dose of the SARS-CoV-2 vaccine via intramuscular injection. |
11 | $117 | $321 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$18,945
Total received (2018-2024)
Avg $2,706/year across 7 years
Top 8% in IL for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
728
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,698 (82.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,226 (17.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$21 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,020
2023
$3,133
2022
$2,870
2021
$1,916
2020
$1,191
2019
$4,633
2018
$1,181
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$846
GlaxoSmithKline, LLC.
$582
United Therapeutics Corporation
$446
Inspire Medical Systems, Inc.
$443
GENZYME CORPORATION
$405
Boehringer Ingelheim Pharmaceuticals, Inc.
$240
Regeneron Healthcare Solutions, Inc.
$200
Takeda Pharmaceuticals U.S.A., Inc.
$165
Electromed, Inc.
$112
Baxter Healthcare
$107
JAZZ PHARMACEUTICALS INC.
$85
Amgen Inc.
$69
Mylan Specialty L.P.
$68
Insmed, Inc.
$53
Pulmonx Corporation
$32
Grifols USA, LLC
$27
Merck Sharp & Dohme LLC
$23
Kiniksa Pharmaceuticals International, plc
$22
Optinose US, Inc.
$21
ANI Pharmaceuticals, Inc.
$21
Actelion Pharmaceuticals US, Inc.
$21
Lexicon Pharmaceuticals, Inc.
$18
Resmed Corp
$16
Top 3 companies account for 46.6% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$3,408
Genentech USA, Inc.
$3,216
AstraZeneca Pharmaceuticals LP
$3,174
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,510
GENZYME CORPORATION
$832
Inspire Medical Systems, Inc.
$743
Regeneron Healthcare Solutions, Inc.
$556
United Therapeutics Corporation
$530
Mylan Specialty L.P.
$522
Grifols USA, LLC
$409
Takeda Pharmaceuticals U.S.A., Inc.
$326
Electromed, Inc.
$323
Vanda Pharmaceuticals Inc.
$267
Amgen Inc.
$251
Insmed, Inc.
$244
JAZZ PHARMACEUTICALS INC.
$217
Phadia US Inc.
$207
Bayer HealthCare Pharmaceuticals Inc.
$192
Teva Pharmaceuticals USA, Inc.
$166
Janssen Pharmaceuticals, Inc
$162
Baxter Healthcare
$160
Sunovion Pharmaceuticals Inc.
$159
COMSORT, Inc
$150
Jazz Pharmaceuticals Inc.
$122
Circassia Pharmaceuticals Inc
$101
Axsome Therapeutics, Inc.
$85
Allergan Inc.
$76
Pulmonx Corporation
$67
PFIZER INC.
$66
Novartis Pharmaceuticals Corporation
$62
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$61
Actelion Pharmaceuticals US, Inc.
$58
Merck Sharp & Dohme LLC
$47
Alexion Pharmaceuticals, Inc.
$47
Philips Electronics North America Corporation
$44
Novo Nordisk Inc
$41
EISAI INC.
$35
E.R. Squibb & Sons, L.L.C.
$31
ADVANCED RESPIRATORY, INC
$31
Resmed Corp
$27
Kiniksa Pharmaceuticals, Ltd.
$26
Medtronic, Inc.
$23
Kiniksa Pharmaceuticals International, plc
$22
Optinose US, Inc.
$21
Mallinckrodt Hospital Products Inc.
$21
Boston Scientific Corporation
$21
ANI Pharmaceuticals, Inc.
$21
Shire North American Group Inc
$20
Lexicon Pharmaceuticals, Inc.
$18
Dexcom, Inc.
$13
Mallinckrodt LLC
$12
Top 3 companies account for 51.7% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSENSE · AIRSUPRA · ALAIR · ANORO · ANORO ELLIPTA · APTIOM · AREXVY · Adempas · AirDuo Digihaler · Arcalyst · Arikayce · Astral · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · CHARTIS CATHETER · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dexcom G6 Transmitter · DreamStat Cpap Auto · ELIQUIS · Edge Navigation · Esbriet · FARXIGA · FASENRA · Fycompa · GLASSIA · HETLIOZ · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · IMFINZI · INSPIRE · ImmunoCAP · Inspire Upper Airway Stimulation System · LONHALA MAGNAIR · LifeVest · NIOX VERO · NONE · NUCALA · OFEV · OPSUMIT · ORENITRAM · PROAIR · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · Repatha · SMARTVEST · SPIRIVA RESPIMAT · STARLING SYSTEM · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Saxenda · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · ULTOMIRIS · UPTRAVI · UTIBRON NEOHALER · VERQUVO · VRAYLAR · Wellcentive Undiv · XARELTO · XOLAIR · XYWAV · Xhance · Xolair · Xyrem · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (83%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for critical care medicine in IL.
Geographic Context
Critical care medicines within 10 mi
12
Per 100K population
5.8
County median income
$63,091
Nearest hospital
THE PAVILION
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Patel is a clinical cardiology specialist, with above-average Medicare volume (top 2% in IL), with low-engagement industry engagement in the top 8% of IL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with allergy blood test (ige), per allergen?
Based on Medicare claims data, Dr. Patel performed 1,345 allergy blood test (ige), per allergen services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $18,945 from 51 companies across 728 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other critical care medicines in Champaign?
Dr. Patel's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Champaign
Browse critical care medicines in Champaign ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in IL
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in IL
Which IL critical care medicines receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology